Form 4: DENTSPLY SIRONA CEO Simon Campion Increases Stake Through RSU Dividends and Employee Plan
Insider Transaction Report
Simon D. Campion, President, CEO, and Director of DENTSPLY SIRONA Inc. (XRAY), reported an increase in his beneficial ownership of common stock and phantom stock through dividend reinvestment and employee stock purchase plan acquisitions.
Summary
- Simon D. Campion, President, CEO, and Director of DENTSPLY SIRONA Inc., reported changes in his beneficial ownership of company securities.
- On July 11, 2025, Campion acquired 1,260.911 shares of common stock, representing dividends on restricted stock units (RSUs) awarded to him, which are subject to the same vesting terms as the underlying awards.
- His total beneficial ownership of common stock following these transactions is 272,403.9801 shares.
- This total includes 370 shares acquired between January 1 and June 30, 2025, under the Dentsply Sirona Employee Stock Purchase Plan.
- It also includes 1,178.392 shares acquired through dividend reinvestment on July 10, 2025.
- Additionally, on July 11, 2025, Campion acquired 131.3974 units of phantom stock under the Supplemental Executive Retirement Plan (SERP) at a price of $16.2 per unit, comprised of accrued dividends.
- Each phantom stock unit is the economic equivalent of one share of common stock and becomes payable in common stock upon termination of employment.
- Following this transaction, Campion beneficially owns 13,353.196 units of phantom stock.
- A Limited Power of Attorney, effective May 22, 2025, authorizes Richard Rosenzweig, Jessica Causey, and Lindi Barton-Brobst to execute Section 16 reports on behalf of Simon D. Campion.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as it indicates an increase in insider holdings, primarily through compensation and dividend reinvestment, which aligns executive interests with shareholders. However, it's a routine compliance filing, not a strategic announcement.
Positives
- Simon D. Campion's beneficial ownership of DENTSPLY SIRONA common stock increased by 1,260.911 shares through RSU dividends, indicating continued alignment with shareholder interests.
- An additional 1,178.392 shares were acquired through dividend reinvestment, demonstrating a commitment to increasing holdings in the company.
- Participation in the Employee Stock Purchase Plan (ESPP) resulted in the acquisition of 370 shares, reflecting confidence in the company's performance.
- The acquisition of 131.3974 phantom stock units through accrued dividends further enhances executive long-term incentives and aligns with company performance.
Future Outlook
This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook.
Industry Context
This filing is a routine insider transaction report, common across all publicly traded companies, providing transparency into executive stock ownership changes. It does not directly relate to broader industry trends or competitive dynamics beyond the executive's personal investment in the company.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | Simon D. Campion granted a Limited Power of Attorney to Richard Rosenzweig, Jessica Causey, and Lindi Barton-Brobst to execute and file Forms 3, 4, and 5 on his behalf, ensuring compliance with Section 16(a) of the Securities Exchange Act of 1934. | 05/22/2025 | This streamlines the process for timely and accurate insider trading compliance filings, enhancing administrative efficiency for the executive and the company. |
Related Party Transactions
- The reported acquisitions of common stock and phantom stock by Simon D. Campion, a director and officer of DENTSPLY SIRONA Inc., are inherently related-party transactions as they involve an executive and the company. These transactions are part of his compensation and benefit arrangements and are routinely disclosed via Form 4 filings.
Stakeholder Impact
- Shareholders: Increased transparency regarding executive stock ownership and compensation, potentially signaling management's confidence in the company's future through increased holdings.
- Employees: The mention of the Employee Stock Purchase Plan (ESPP) indicates a benefit program available to employees, fostering broader employee ownership.
Key Dates
| Date | Description |
|---|---|
| 05/22/2025 | Effective date of the Limited Power of Attorney granted by Simon D. Campion for Section 16 reporting obligations. |
| 01/01/2025 06/30/2025 | Period during which 370 shares were acquired under the Dentsply Sirona Employee Stock Purchase Plan. |
| 07/10/2025 | Date of acquisition of 1,178.392 shares through dividend reinvestment. |
| 07/11/2025 | Transaction date for the acquisition of 1,260.911 common stock shares (RSU dividends) and 131.3974 phantom stock units (accrued dividends). |
| 07/15/2025 | Date the Form 4 was signed by the Attorney-In-Fact for Simon D. Campion. |
Keywords
DENTSPLY SIRONA, XRAY, Form 4, Insider Transaction, Stock Acquisition, Beneficial Ownership, Restricted Stock Units, RSU, Phantom Stock, SERP, Employee Stock Purchase Plan, ESPP, Executive Compensation, Dividend Reinvestment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.